Basal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Basal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes [Phase 2]
Phase 2 trial update evaluating the efficacy of oral vismodegib across basal cell carcinoma subtypes completed with results posted.
-
FDA approval · 2019-05-13FDA Approved: ODOMZO — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ODOMZO (sonidegib) submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating superficial basal cell carcinoma treated with photodynamic therapy using three photosensitizers (HAL, BF…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy [Phase 3]
Phase 3 trial update for photodynamic therapy in non-aggressive basal cell carcinoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab with or without vismodegib for metastatic or unresectable basal cell carcinoma has completed with p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
A clinical trial update on the acceptability and frequency of writing advanced directives among onco-dermatology patients.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of sonidegib and buparlisib in advanced or metastatic basal cell carcinoma was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas [Phase 2]
Phase 2 trial evaluating patidegib gel at 2% and 4% vs vehicle to reduce GLI1 biomarker in sporadic nodular basal cell carcinomas; study com…
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas [Phase 2]
A Phase 2 pilot biomarker trial evaluated itraconazole for efficacy in basal cell carcinoma; trial completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser [NA]
A randomized pilot trial evaluated a laser-based treatment for nodular and superficial basal cell carcinoma; results were posted after compl…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas [Phase 1]
This Phase 1 trial update reports results for the combination of photodynamic therapy and vismodegib in patients with multiple basal cell ca…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate [Phase 1, Phase 2]
Clinical trial update for basal cell carcinoma treated with ablative fractional laser and Ingenol Mebutate (Phase 1/2) has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of ASN-002 in adults with low-risk nodular basal cell carcinoma, focusing …
-
CLINICAL_TRIALS research · 2018-04-20Clinical Trial Update: Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope [NA]
This clinical trial update discusses using the Spectra-Scope to diagnose melanoma, squamous cell carcinoma, and basal cell carcinoma of the …
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study [Phase 2]
This completed Phase 2 trial evaluated the safety and efficacy of Oshadi D and Oshadi R in basal cell carcinoma patients prior to tumor exci…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: Intraoperative Detection of Residual BCC by Fast Raman
The document reports an ongoing clinical trial from the University of Nottingham evaluating a Fast Raman device to detect residual basal cel…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
The trial registry entry indicates completion of a study on confocal reflectance microscopy of shave-biopsy skin sites in vivo, including in…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina
This is a completed observational study of vismodegib (Erivedge) in patients with basal cell carcinoma treated in Argentina.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) [NA]
A completed clinical trial comparing a new MAL-PDT regimen to an approved MAL-PDT regimen for basal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) [EARLY_Phase 1]
An early phase 1 trial evaluated vismodegib in patients with basal cell carcinoma, including recurrent skin cancer. Results were posted in 2…
-
FDA approval · 2017-09-18FDA Approved: ODOMZO — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ODOMZO (sonidegib) by Sun Pharmaceutical Industries.
-
FDA approval · 2017-08-01FDA Approved: ERIVEDGE — Supplemental Application (Genentech, Inc.)
The FDA approved Genentech's supplemental application for ERIVEDGE (vismodegib). The action updates the product's labeling and indications f…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
The RegiSONIC observational study evaluating treatment patterns and effectiveness and safety in advanced basal cell carcinoma and nevoid bas…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants
Completed Roche-sponsored study analyzing treatment patterns and outcomes in Basal Cell Carcinoma participants.
-
CLINICAL_TRIALS withdrawal · 2017-07-06Clinical Trial Update: Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery [NA]
The clinical trial investigating same-day versus separate-day preoperative consultation for Mohs surgery has been withdrawn. It targeted non…